-
NIH awards Delix $320K to advance neuroplastogen for substance use disorders
20 Dec 2023 17:25 GMT
… Drug Abuse to advance its novel, non-hallucinogenic neuroplastogen for treatment … intramuscularly.
NIH has awarded Delix Therapeutics $320K in grant … hallucinogenic properties and administration limitations,” Delix Chief Scientific Officer Kurt Rasmussen …
-
New psychedelic-like drugs: All treatment, no trip?
12 Dec 2023 14:19 GMT
… adverse effects. His biotech startup, Delix Therapeutics, has … Stanford University School of Medicine investigators Dr. Boris … Drugs,” tightened regulations and disappointing clinical trials.
Psychedelic drugs … a treatment for PTSD, based on clinical trial …
-
Delix Therapeutics Awarded National Institutes of Health Grant to Advance Vital Research of Novel Neuroplastogen for Substance Use Disorders
13 Dec 2023 13:17 GMT
… uncover more effective treatments for the medical management of substance … from its Phase 1 trial evaluating the safety, … a proprietary phenotypic drug discovery engine, Delix seeks to bring … bring patients FDA-approved, take-home medicines that will …
-
Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting
06 Dec 2023 13:20 GMT
… potential to shift the treatment paradigm for several … of the Regenerative Medicine Division at Shire Pharmaceuticals. Earlier on … had rapid and enduring antidepressant-like effects after a … from our phenotypic drug discovery engine, Delix’s seeks to …
-
Do You Need to 'Trip' for Psychedelics to Work as Medicine?
08 Nov 2023 19:51 GMT
… Medical School in Germany. He’s been researching psychedelic drugs … also co-founder of Delix Therapeutics, a biotech company that’s … and the complexity of the treatment.
If we don’t … results seen in some clinical trials with psychedelics.
Dölen: Learning …
-
Non-Hallucinogenic Drug Inspired by Psychedelics Enters First-in-Human Study
22 Aug 2023 14:16 GMT
… supervision of medical professionals.
Clinical research company Delix Therapeutics … Delix hopes to develop these drugs as at-home treatments with … a Phase 1 clinical trial of its first … something.
With traditional antidepressants, it doesn’t happen that …
-
Six biotech spinouts you should watch out for this year
04 Jul 2023 17:02 GMT
… newer treatments. Delix Therapeutics has discovered a class of drugs … the field of regenerative medicine, specifically in limb regeneration … to proceed with human trials.
Founded three years … financing round included British biotech company Juvenescence and …
-
Delix Therapeutics Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in Phase I Trial for Novel Compound DLX-001
20 Jun 2023 17:11 GMT
… trial is expected in early 2024. An Investigational New Drug … be approved for human trials. Delix's innovative … to bring patients FDA-approved, take-home medicines that will … biotechnology company by combining an experienced team with innovative treatment …
-
With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures
13 Jun 2023 07:51 GMT
… , diagnostics, clinical trials, and health screening … allowing for personalized treatment options.”
Tapping … , pharmaceuticals, and other factors,” said Range Biotechnologies’ … including pharmacodynamics, diagnostic medicine, drug discovery, food safety …
-
Delix Therapeutics completes dose study for DLX-001
21 Jun 2023 14:42 GMT
… established during the clinical trial, determining bioavailability and oral … treatment of depression.”
Mark Rus, chief executive officer at Delix, … trial is being held at the Center for Human Drug … clinical drug research. Complete phase 1 data for the trial …